Captrust Financial Advisors Compass Pathways PLC Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$6.76 - $14.18 $169 - $354	-25 Reduced 0.96%	2,574 $28,000
Q1 2022 May 16, 2022	BUY	$11.13 - $23.04 $278 - $576	25 Added 0.97%	2,599 $34,000
Q4 2021 Feb 14, 2022	BUY	$21.81 - $48.96 $45,888 - $103,011	2,104 Added 447.66%	2,574 $57,000
Q2 2021 Aug 16, 2021	BUY	$32.29 - $39.68 $645 - $793	20 Added 4.44%	470 $18,000
Q1 2021 May 17, 2021	BUY	$34.75 - $57.5 $3,475 - $5,750	100 Added 28.57%	450 $17,000
Q4 2020 Feb 16, 2021	BUY	$32.0 - $59.2 $11,200 - $20,720	350 New	350 $17,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.